Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	5441	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	5612	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	6329	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	7668	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	9572	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	10283	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	11281	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	11661	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	12026	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	12306	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	12510	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	12763	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	13342	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	13418	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	13685	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	13767	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	14114	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	14145	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	14432	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	14786	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	14800	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	14873	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	15306	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	15486	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	15564	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	15730	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	15745	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	15761	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16080	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16294	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16497	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16557	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16814	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16887	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	16977	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17027	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17065	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17174	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17296	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17296	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17540	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17571	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	17810	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18219	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18350	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18482	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18517	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18577	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18591	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18624	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	18870	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	19043	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	19075	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	19165	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	19269	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	19481	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	20407	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	20609	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	21053	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	21200	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	21606	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	21640	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	21879	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	22414	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	22704	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	23244	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	23366	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	23371	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	23391	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	23694	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	23980	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24089	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24103	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24149	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24156	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24250	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24350	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24441	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	24529	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	25127	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	26274	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	26411	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	28101	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	28462	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-	32035	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+	1305	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+	3810	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	DEOXYADENOSINE (CAS# 16373-93-6); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y